247 related articles for article (PubMed ID: 24263237)
1. Novel molecular targets of dezocine and their clinical implications.
Liu R; Huang XP; Yeliseev A; Xi J; Roth BL
Anesthesiology; 2014 Mar; 120(3):714-23. PubMed ID: 24263237
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist.
Wang YH; Chai JR; Xu XJ; Ye RF; Zan GY; Liu GY; Long JD; Ma Y; Huang X; Xiao ZC; Dong H; Wang YJ
Sci Rep; 2018 Sep; 8(1):14087. PubMed ID: 30237513
[TBL] [Abstract][Full Text] [Related]
3. Dual μ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain.
Mao XF; Ahsan MZ; Apryani E; Tang XQ; Zhao MJ; Li XY; Wang YX
Eur J Pharmacol; 2020 Jun; 876():173062. PubMed ID: 32173379
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of dezocine, pentazocine and tapentadol on antinociception and physical dependence.
Ahsan MZ; Zhao MJ; Shoaib RM; Zhang Y; Wang YX
Life Sci; 2021 Nov; 285():119996. PubMed ID: 34597607
[TBL] [Abstract][Full Text] [Related]
5. Effects of dezocine on morphine tolerance and opioid receptor expression in a rat model of bone cancer pain.
Wu LX; Dong YP; Zhu QM; Zhang B; Ai BL; Yan T; Zhang GH; Sun L
BMC Cancer; 2021 Oct; 21(1):1128. PubMed ID: 34670518
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like effects of dezocine in mice: involvement of 5-HT1A and κ opioid receptors.
Shang L; Duan C; Chang S; Chang N; Jia S
Behav Pharmacol; 2021 Sep; 32(6):472-478. PubMed ID: 34101632
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
Picker MJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
[TBL] [Abstract][Full Text] [Related]
8. Dezocine exhibits antihypersensitivity activities in neuropathy through spinal μ-opioid receptor activation and norepinephrine reuptake inhibition.
Wang YX; Mao XF; Li TF; Gong N; Zhang MZ
Sci Rep; 2017 Feb; 7():43137. PubMed ID: 28230181
[TBL] [Abstract][Full Text] [Related]
9. Dezocine Alleviates Morphine-Induced Dependence in Rats.
Wu FX; Babazada H; Gao H; Huang XP; Xi CH; Chen CH; Xi J; Yu WF; Liu R
Anesth Analg; 2019 Jun; 128(6):1328-1335. PubMed ID: 31094808
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
11. The bovine pineal gland contains delta and mu but not kappa or ORL1 opioid receptor subtypes.
Govitrapong P; Sawlom S; Chetsawang B; Sangchot P; Ebadi M
Proc West Pharmacol Soc; 2002; 45():32-5. PubMed ID: 12434519
[No Abstract] [Full Text] [Related]
12. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
Ananthan S; Khare NK; Saini SK; Davis P; Dersch CM; Porreca F; Rothman RB
Bioorg Med Chem; 2003 Sep; 11(18):4143-54. PubMed ID: 12927876
[TBL] [Abstract][Full Text] [Related]
13. L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors.
Sbrenna S; Marti M; Morari M; Calo G; Guerrini R; Beani L; Bianchi C
J Pharmacol Exp Ther; 1999 Dec; 291(3):1365-71. PubMed ID: 10565862
[TBL] [Abstract][Full Text] [Related]
14. Dezocine as a potent analgesic: overview of its pharmacological characterization.
Ye RR; Jiang S; Xu X; Lu Y; Wang YJ; Liu JG
Acta Pharmacol Sin; 2022 Jul; 43(7):1646-1657. PubMed ID: 34737418
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
[TBL] [Abstract][Full Text] [Related]
16. The presence of delta and mu-, but not kappa or ORL(1) receptors in bovine pinealocytes.
Govitrapong P; Sawlom S; Ebadi M
Brain Res; 2002 Sep; 951(1):23-30. PubMed ID: 12231452
[TBL] [Abstract][Full Text] [Related]
17. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine.
Chen JC; Smith ER; Cahill M; Cohen R; Fishman JB
Life Sci; 1993; 52(4):389-96. PubMed ID: 8093631
[TBL] [Abstract][Full Text] [Related]
18. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
Fischer BD; Miller LL; Henry FE; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 2008 Jun; 198(2):271-8. PubMed ID: 18392754
[TBL] [Abstract][Full Text] [Related]
19. Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.
Munro TA; Huang XP; Inglese C; Perrone MG; Van't Veer A; Carroll FI; Béguin C; Carlezon WA; Colabufo NA; Cohen BM; Roth BL
PLoS One; 2013; 8(8):e70701. PubMed ID: 23976952
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
